Drugs Made In America Acquisition II Corp. has announced the execution of a Definitive Investment and Sponsor Transition Agreement with Alpha Multi Family Office, securing an initial $150,000 through an unsecured convertible note, referred to as the Bridge Note. This financing is part of a larger anticipated $1,400,000 Convertible Notes Financing, aimed at facilitating the company's upcoming business combination. The company has also entered into an Interim Convertible Note for an additional $300,000, which is set to mature in nine months unless converted earlier. The proceeds from this financing will be allocated towards accounting and audit expenses related to the business combination. The terms of the financing include a conversion option for the investor at a 35% discount to the market price upon the completion of the business combination. This strategic move is expected to bolster the company's liquidity and support its operational execution as it prepares for its initial business combination.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.